Stock index futures pointed to a lower open for Wall Street, but were off the day's lows as Dow component Merck announced it will merge with Schering-Plough in a cash and stock deal. The companies value the merger at $41.1 billion, or $23.61 per share of Schering stock, which is a 34% premium compared to Friday's closing price. Schering-Plough shareholders will receive 0.5767 Merck shares and $10.50 in cash for each share of Schering-Plough. The deal comes less than two months after Pfizer Inc., the world’s biggest drug maker, agreed to buy Wyeth for about $62 billion, and would make Merck the second-biggest drug maker.
The early part of the week is light on economic data. Thursday will be the release of the Commerce Department’s retail-sales report for February and the weekly initial jobless claims. On Friday, we will get trade data, along with a report on consumer sentiment.